3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
23
Sarcoma
18
Neoplasms
8
Neoplasm Metastasis
8
Breast Neoplasms
8
Ovarian Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Fallopian Tube Neoplasms
6
Liposarcoma
5
Leiomyosarcoma
5
Hemangiosarcoma
5
Sarcoma, Synovial
4
Neurofibrosarcoma
4
Lung Neoplasms
4
Kidney Neoplasms
4
Histiocytoma, Malignant Fibrous
4
Urinary Bladder Neoplasms
3
Recurrence
3
Prostatic Neoplasms
3
Glioblastoma
3
Thyroid Carcinoma, Anaplastic
2
Small Cell Lung Carcinoma
2
Sarcoma, Alveolar Soft Part
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Melanoma
2
Gliosarcoma
2
Fibrosarcoma
2
Dermatofibrosarcoma
2
Clear-cell metastatic renal cell carcinoma
2
Interventions
Paclitaxel
5
Carboplatin
3
Taxes
2
Specimen Handling
2
Nivolumab
2
Biopsy
2
rucaparib
1
rebastinib
1
pembrolizumab
1
olaparib
1
durvalumab
1
cediranib
1
capivasertib
1
cabozantinib
1
Magnetic Resonance Spectroscopy
1
LY-2157299
1
Immunoglobulin G
1
Ifosfamide
1
Fluid Therapy
1
Disulfides
1
DCC-2036
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinosarcoma
×
pazopanib
×
Clear all
No trials found.